Comment from University of Massachusetts Dept of Obstetrics and Gynecology

Summary: Dr. Christopher Longcope, a professor of Obstetrics & Gynecology at the University of Massachusetts Medical Center, argues against the FDA's decision to discontinue combined estrogen/androgen drugs. He provides clinical evidence that these combination therapies are effective for improving bone density, psychological symptoms, and vasomotor symptoms in postmenopausal women compared to estrogen alone.